Accuray (ARAY) Competitors

Surmodics (NASDAQ:SRDX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Which has better valuation & earnings, SRDX or ARAY?

Surmodics has higher earnings, but lower revenue than Accuray.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surmodics	$126.08M	4.09	-$11.54M	-$1.39	-25.92
Accuray	$465.25M	0.31	-$15.55M	N/A	N/A

Do analysts recommend SRDX or ARAY?

Surmodics currently has a consensus target price of $43.00, suggesting a potential upside of 19.34%. Given Surmodics' stronger consensus rating and higher possible upside, research analysts plainly believe Surmodics is more favorable than Accuray.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surmodics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Accuray	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media prefer SRDX or ARAY?

In the previous week, Surmodics had 2 more articles in the media than Accuray. MarketBeat recorded 4 mentions for Surmodics and 2 mentions for Accuray. Surmodics' average media sentiment score of 1.32 beat Accuray's score of 0.88 indicating that Surmodics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surmodics	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accuray	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is SRDX or ARAY more profitable?

Accuray has a net margin of 0.14% compared to Surmodics' net margin of -16.34%. Accuray's return on equity of 1.43% beat Surmodics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surmodics	-16.34%	-7.10%	-4.77%
Accuray	0.14%	1.43%	0.14%

Do institutionals and insiders hold more shares of SRDX or ARAY?

96.6% of Surmodics shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 8.9% of Surmodics shares are held by company insiders. Comparatively, 4.2% of Accuray shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has more risk & volatility, SRDX or ARAY?

Surmodics has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Accuray has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Summary

Surmodics beats Accuray on 10 of the 14 factors compared between the two stocks.